Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials

Science Translational Medicine
Elizabeth M Berry-KravisFlorian von Raison

Abstract

Fragile X syndrome (FXS), the most common cause of inherited intellectual disability and autistic spectrum disorder, is typically caused by transcriptional silencing of the X-linked FMR1 gene. Work in animal models has described altered synaptic plasticity, a result of the up-regulation of metabotropic glutamate receptor 5 (mGluR5)-mediated signaling, as a putative downstream effect. Post hoc analysis of a randomized, placebo-controlled, crossover phase 2 trial suggested that the selective mGluR5 antagonist mavoglurant improved behavioral symptoms in FXS patients with completely methylated FMR1 genes. We present the results of two phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies of mavoglurant in FXS, designed to confirm this result in adults (n = 175, aged 18 to 45 years) and adolescents (n = 139, aged 12 to 17 years). In both trials, participants were stratified by methylation status and randomized to receive mavoglurant (25, 50, or 100 mg twice daily) or placebo over 12 weeks. Neither of the studies achieved the primary efficacy end point of improvement on behavioral symptoms measured by the Aberrant Behavior Checklist-Community Edition using the FXS-specific algorithm (ABC-C(FX)) a...Continue Reading

References

Sep 23, 2000·The Journal of Neuropsychiatry and Clinical Neurosciences·D I KauferS T DeKosky
Jan 25, 2002·Journal of Child Psychology and Psychiatry, and Allied Disciplines·T ManlyI H Robertson
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kimberly M HuberMark F Bear
Sep 13, 2003·Health Technology Assessment : HTA·F J SongA Fry-Smith
Jun 29, 2004·Trends in Neurosciences·Mark F BearStephen T Warren
Oct 4, 2006·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·C Thomas Gualtieri, Lynda G Johnson
Oct 19, 2006·Journal of Autism and Developmental Disorders·Kristen S L Lam, Michael G Aman
Feb 5, 2011·American Journal on Intellectual and Developmental Disabilities·Sigan L HartleyDonald B Bailey
Feb 15, 2011·Neurobiology of Disease·Josien LevengaBen A Oostra
Oct 6, 2011·Journal of Autism and Developmental Disorders·Stephanie M SansoneDavid Hessl
Apr 17, 2012·Neuron·Aubin MichalonLothar Lindemann
Apr 24, 2012·Neuroscience·C X He, C Portera-Cailliau
Nov 13, 2012·Behavioural Brain Research·Ilse GantoisRob Willemsen
Apr 16, 2013·Nature Neuroscience·Jennifer C Darnell, Eric Klann
May 8, 2013·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Dimitrios I ZafeiriouEuthymia Vargiami
Jul 5, 2013·American Journal of Medical Genetics. Part a·Magdalena DziembowskaFlora Tassone
Aug 29, 2013·Journal of Psychopharmacology·Andrea SchneiderDavid Hessl
Oct 30, 2013·Frontiers in Neuroscience·Esperanza FernándezClaudia Bagni
Apr 5, 2014·American Journal of Medical Genetics. Part a·Jessica HunterJose Leal

❮ Previous
Next ❯

Citations

Jan 15, 2016·Science Translational Medicine·Shafali S Jeste, Daniel H Geschwind
Mar 12, 2016·Science·J Peter H Burbach
Sep 28, 2016·Intractable & Rare Diseases Research·Andrew Ligsay, Randi J Hagerman
Oct 30, 2016·Biochimie·Ricardos TabetHervé Moine
Dec 3, 2016·Regenerative Medicine·Dan Vershkov, Nissim Benvenisty
Mar 25, 2017·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M-L Rouzade-DominguezA Rühl
Jan 10, 2017·Expert Opinion on Therapeutic Patents·Kyle A Emmitte
May 16, 2017·Nature Medicine·Ilse GantoisNahum Sonenberg
Jun 28, 2017·British Journal of Clinical Pharmacology·Serge Cremers, Jeffrey K Aronson
Jun 14, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jacob J Michaelson
Dec 9, 2017·Nature Reviews. Drug Discovery·Elizabeth M Berry-KravisSébastien Jacquemont
Mar 27, 2018·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Jonathan Green, Shruti Garg
Apr 19, 2018·International Review of Psychiatry·James Harris
Nov 23, 2017·Frontiers in Synaptic Neuroscience·Sara CastagnolaThomas Maurin
Dec 21, 2017·F1000Research·Akash RajaratnamRandi Hagerman
Mar 29, 2018·Human Molecular Genetics·Sébastien JacquemontClaudia Bagni
Dec 19, 2018·Brain Sciences·Craig A EricksonElizabeth Berry-Kravis
Feb 2, 2018·Current Opinion in Neurology·Evdokia Anagnostou
Feb 13, 2019·Journal of Intellectual Disability Research : JIDR·C S D'AmandaB B Biesecker
Nov 6, 2018·Clinical Science·Phuc N H TrinhKaren J Gregory
Aug 30, 2016·Nature Neuroscience·Charles G JenningsGuoping Feng
Sep 30, 2017·Nature Reviews. Disease Primers·Randi J HagermanPaul J Hagerman
Feb 1, 2018·Lab Animal·Alla Katsnelson
May 3, 2019·Current Opinion in Neurology·Hidenori YamasueElizabeth Berry-Kravis
Apr 13, 2017·Translational Neuroscience·Phan Q Duy, Dejan B Budimirovic
Jun 27, 2017·Molecular Autism·Tiffany D RogersJeremy Veenstra-VanderWeele
Aug 17, 2019·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Jessica KlusekJane E Roberts
Aug 5, 2017·Molecular Autism·Hendrik WesselingSabine Bahn
Sep 15, 2017·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Christopher M McGrawRodney C Samaco
Sep 25, 2019·Nature Medicine·Stephan J SandersCarrie E Bearden
Oct 30, 2019·Current Topics in Medicinal Chemistry·Junliang Hao, Qi Chen
Sep 24, 2019·Biometrical Journal. Biometrische Zeitschrift·Marius ThomasFranz König
Nov 5, 2019·Current Pharmaceutical Design·Michael Telias
Mar 29, 2019·Neurology·Randi Hagerman, Roberto Tuchman
May 16, 2017·Journal of Neurodevelopmental Disorders·Michael S SidorovBenjamin D Philpot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.